Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia

Journal of Clinical Microbiology

Volumn 38, Issue 1, 2000, Pages 408-411

  Kónya, József ^a   Veress, György ^a   Juhász, Attila ^a   Szarka, Krisztina ^a   Sápy, Tamás ^a   Hernádi, Zoltán ^a   Gergely, Lajos ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLPOSCOPY; CORRELATION FUNCTION; FEMALE; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

CERVIX UTERI; COLPOSCOPY; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REAGENT KITS, DIAGNOSTIC; RNA PROBES; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; TUMOR VIRUS INFECTIONS;

EID: 0343938891     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PS1-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25-3389-3402.
2. Bernard, H. U., S. Y. Chan, M. M. Manos, C. K. Ong, L. L. Villa, H. Delius, C. L. Peyton, H. M. Bauer, and C. M. Wheeler. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170:1077-1085.
3. Cope, J. U., A. Hildesheim, M. H. Schiffman, M. M. Manos, A. T. Lorincz, R. D. Burk, A. G. Glass, C. Greer, J. Buckland, K. Helgesen, D. R. Scott, M. E. Sherman, R. J. Kurman, and K. L. Liaw. 1997. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J. Clin. Microbiol. 35:2262-2265.
4. Cox, J. T., A. T. Lorincz, M. H. Schiffman, M. E. Sherman, A. Cullen, and R. J. Kurman. 1995. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am. J. Obstet. Gynecol. 172: 946-954.
5. Dillner, J. 1998. Can cervical cancer screening programs be improved by incorporating screening for human papillomavirus infections? Cancer J. 11: 272-276.
6. Ferenezy, A., E. Franco, J. Arseneau, T. C. Wright, and R. M. Richart. 1996. Diagnostic performance of hybrid capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am. J. Obstet. Gynecol. 175:651-656.
7. Ferris, D. G., T. C. Wright, Jr., M. S. Litaker, R. M. Richart, A. T. Lorincz, X. W. Sun, L. Borgatta, H. Buck, L. Kramer, and R. Rubin. 1998 Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? J. Fam. Pract. 46:125-134.
8. Hildesheim, A., M. H. Schiffman, P. E. Gravitt, A. G. Glass, C. E. Greer, T. Zhang, D. R. Scott, B. B. Rush, P. Lawler, M. E. Sherman, et al. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169:235-240.
9. Ho, G. Y., R. D. Burk, S. Klein, A. S. Kadish, C. J. Chang, P. Palan, J. Basu, R. Tachezy, R. Lewis, and S. Romney. 1995. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. 87:1365-1371.
10. Koutsky, L. A., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonen, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, O. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327: 1272-1278.
11. Lorincz, A. T. 1996. Hybrid capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J. Obstet. Gynaecol. Res. 22:629-636.
12. Manos, M. M., Y. Ting, D. K. Wright, A. J. Lewis, T. R. Broker, and S. M. Wolinsky. 1989. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
13. Melbye, M., E. Smith, J. Wohlfahrt, A. Osterlind, M. Orholm, O. J. Bergmann, L. Mathiesen, T. M. Darragh, and J. M. Palefsky. 1996. Anal and cervical abnormality in women - prediction by human papillomavirus tests. Int. J. Cancer 68:559-564.
14. Nindl, I., C. Greinke, D. M. Zahm, E. Stockfleth, H. Hoyer, and A. Schneider. 1997. Human papillomavirus distribution in cervical tissues of different morphology as determined by hybrid capture assay and PCR. Int. J. Gynecol. Pathol. 16:197-204.
15. Nobbenhuis, M. A., J. M. Walboomers, T. J. Helmerhorst, L. Rozendaal, A. J. Remmink, E. K. Risse, H. C. van der Linden, F. J. Voorhorst, P. Kenemans, and C. J. Meijer. 1999. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354:20-25.
16. Peyton, C. L., M. Schiffman, A. T. Lorincz, W. C. Hunt, I. Mielzynska, C. Bratti, S. Eaton, A. Hildesheim, L. A. Morera, A. C. Rodriguez, R. Herrero, M. E. Sherman, and C. M. Wheeler. 1998, Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J. Clin. Microbiol. 36:3248-3254.
17. Ponten, J., H. O. Adami, R. Bergstrom, J. Dillner, L. G. Friberg, L. Gustafsson, A. B. Miller, D. M. Parkin, P. Sparen, and D. Trichopoulos. 1995. Strategies for global control of cervical cancer. Int. J. Cancer 60:1-26.
18. Saiki, R. K., S. Scharf, F. Faloona, K. B. Mullis, G. T. Horn, H. A. Erlich, and N. Arnheim. 1985. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354.
19. Schiffman, M. H., N. B. Kiviat, R. D. Burk, K. V. Shah, R. W. Daniel, R. Lewis, J. Kuypers, M. M. Manos, D. R. Scott, M. E. Sherman, et al. 1995. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J. Clin. Microbiol. 33:545-550.
20. Sherman, M. E., M. H. Schiffman, A. T. Lorincz, R. Herrero, M. L. Hutchinson, C. Bratti, D. Zahniser, J. Morales, A. Hildesheim, K. Helgesen, D. Kelly, M. Alfaro, F. Mena, I. Balmaceda, L. Mango, and M. Greenberg. 1997. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer 81:89-97.